FTSE techMARK mediscience will provide investors in small and mid-sized companies from the healthcare industry with the only accurate and independent measurement tool of this market. The new index forms part of the FTSE techMARK Index Series, and will be reviewed quarterly, by an independent Committee of market users.
Mark Makepeace, FTSE's Chief Executive said, "The FTSE Group designs and calculates indices for investors worldwide and covers specialist as well as mainstream markets. We believe in innovation, and are committed to developing initiatives in response to market demand, so it's a natural step for FTSE to create an index to support techMARK mediscience."
Martin Wheatley, Deputy CEO, London Stock Exchange said "The mediscience industry attracts a lot of interest - from issuers, investors, intermediaries and the media alike. By providing focus, techMARK mediscience will draw liquidity to this new market and make investment decisions easier."
